Real-world assessment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nasopharyngeal swab testing in a region with a high burden of coronavirus disease 2019 (COVID-19)
Concerns persist regarding possible false-negative results that may compromise COVID-19 containment. Although obtaining a true false-negative rate is infeasible, using real-life observations, the data suggest a possible false-negative rate of ˜2.3%. Use of a sensitive, amplified RNA platform should reassure healthcare systems.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Infection control and hospital epidemiology - 43(2022), 8 vom: 14. Aug., Seite 1051-1053 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sangal, Rohit B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.08.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/ice.2021.153 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323792618 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323792618 | ||
| 003 | DE-627 | ||
| 005 | 20231225184936.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/ice.2021.153 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1079.xml |
| 035 | |a (DE-627)NLM323792618 | ||
| 035 | |a (NLM)33823949 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sangal, Rohit B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world assessment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nasopharyngeal swab testing in a region with a high burden of coronavirus disease 2019 (COVID-19) |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.08.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Concerns persist regarding possible false-negative results that may compromise COVID-19 containment. Although obtaining a true false-negative rate is infeasible, using real-life observations, the data suggest a possible false-negative rate of ˜2.3%. Use of a sensitive, amplified RNA platform should reassure healthcare systems | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Peaper, David R |e verfasserin |4 aut | |
| 700 | 1 | |a Rothenberg, Craig |e verfasserin |4 aut | |
| 700 | 1 | |a Fadlallah, Hasan |e verfasserin |4 aut | |
| 700 | 1 | |a Mobolaji-Lawal, Motunrayo |e verfasserin |4 aut | |
| 700 | 1 | |a Landry, Marie L |e verfasserin |4 aut | |
| 700 | 1 | |a Sussman, L Scott |e verfasserin |4 aut | |
| 700 | 1 | |a Ulrich, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Venkatesh, Arjun K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection control and hospital epidemiology |d 1988 |g 43(2022), 8 vom: 14. Aug., Seite 1051-1053 |w (DE-627)NLM012701467 |x 1559-6834 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:8 |g day:14 |g month:08 |g pages:1051-1053 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/ice.2021.153 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 8 |b 14 |c 08 |h 1051-1053 | ||